De Bruijn M L, Schumacher T N, Nieland J D, Ploegh H L, Kast W M, Melief C J
Division of Immunology, The Netherlands Cancer Institute, Amsterdam.
Eur J Immunol. 1991 Dec;21(12):2963-70. doi: 10.1002/eji.1830211210.
The antigen processing-defective mutant cell line RMA-S expresses at the cell surface major histocompatibility complex (MHC) class I molecules devoid of peptide that can be efficiently loaded with exogenous immunogenic peptides. We now report that viral peptide-loaded RMA-S cells, unlike parental RMA cells, can induce primary cytotoxic T lymphocyte (CTL) responses in vitro, in a T helper cell-independent fashion. This was shown for an H-2Kb-binding peptide of Sendai virus nucleoprotein and an H-2Db-binding peptide of adenovirus type 5 E1A protein with responding spleen cells of C57BL/6 mice, the strain of origin of RMA and RMA-S cells. Primary Sendai peptide-induced CTL lyse both peptide-loaded and virus-infected cells. Pre-culture of RMA-S cells at low temperature (22 degrees - 26 degrees C), which increases the amount of empty MHC class I molecules at the cell surface, decreases the peptide concentrations required for the induction of primary CTL responses. Primary peptide-specific CTL responses induced by peptide-loaded RMA-S cells are CD4+ cell- and MHC class II+ cell-independent. CTL response induction is blocked by the presence of anti-CD8 monoclonal antibody during culture. Direct peptide binding studies confirm the efficient loading of empty MHC molecules on RMA-S cells with peptide and show 2.5-fold more peptide bound per RMA-S cell compared to RMA cells. An additional factor explaining the difference in primary response induction between RMA and RMA-S cells is related to the CD8 dependence of these responses. MHC class I molecules occupied with irrelevant peptides (a majority present on RMA, largely absent on RMA-S) may interfere in the interaction of the CD8 molecule with relevant MHC/peptide complexes. The results delineate a novel strategy of peptide based in vitro immunization to elicit CD8+ cytotoxic T cell responses.
抗原加工缺陷型突变细胞系RMA-S在细胞表面表达缺乏肽段的主要组织相容性复合体(MHC)I类分子,这些分子可有效加载外源性免疫原性肽段。我们现在报告,与亲本RMA细胞不同,加载病毒肽的RMA-S细胞能够以不依赖T辅助细胞的方式在体外诱导原发性细胞毒性T淋巴细胞(CTL)反应。对于仙台病毒核蛋白的H-2Kb结合肽和5型腺病毒E1A蛋白的H-2Db结合肽,用RMA和RMA-S细胞起源的C57BL/6小鼠的反应性脾细胞证明了这一点。原发性仙台肽诱导的CTL可裂解加载肽的细胞和病毒感染的细胞。在低温(22摄氏度 - 26摄氏度)下预培养RMA-S细胞,这会增加细胞表面空MHC I类分子的数量,降低诱导原发性CTL反应所需的肽浓度。加载肽的RMA-S细胞诱导的原发性肽特异性CTL反应不依赖CD4 +细胞和MHC II类+细胞。在培养过程中,抗CD8单克隆抗体的存在会阻断CTL反应的诱导。直接肽结合研究证实了空MHC分子在RMA-S细胞上与肽的有效加载,并显示每个RMA-S细胞结合的肽比RMA细胞多2.5倍。另一个解释RMA和RMA-S细胞之间原发性反应诱导差异的因素与这些反应对CD8的依赖性有关。被无关肽占据的MHC I类分子(RMA上存在大多数,RMA-S上基本不存在)可能会干扰CD8分子与相关MHC/肽复合物的相互作用。这些结果描绘了一种基于肽的体外免疫新策略,以引发CD8 +细胞毒性T细胞反应。